Skip to main content
. 2019 Feb 27;25(9):1569–1576. doi: 10.1093/ibd/izz030

TABLE 5.

Review of the Literature

Reference No. Patients Prior anti-TNF exposure (n, %) Clinical response (n, %) Endoscopic response (n, %)
Bar et al. 18 20 11 (55) 13 (65) 9 (64.3)
Khan et al. 21 12 8 (66.7) 8 (66.7) 10 (83.3)
Philpott et al. 12 4 4 (100) 4 (100) 4 (100)
Shelton et al. 13 8a Not reported 6 (75) Not reported
Coletta et al. 16 1 1 (100) 1 (100) 1 (100)
Bethge et al. 17 1 1 (100) 1 (100) 1 (100)
Schmid et al. 15 1 0 (0) 1 (100) 1 (100)

aAn additional patient with pouchitis was treated with vedolizumab but did not have efficacy data.